TRPC4
Basic information
Region (hg38): 13:37632063-37869802
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Autism, susceptiblity to (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPC4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 30 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 0 | 30 | 0 | 2 |
Highest pathogenic variant AF is 0.00000682
Variants in TRPC4
This is a list of pathogenic ClinVar variants found in the TRPC4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-37636909-T-C | Benign (Dec 31, 2019) | |||
13-37636971-T-C | not specified | Uncertain significance (Jun 06, 2023) | ||
13-37637100-C-T | not specified | Uncertain significance (Oct 06, 2022) | ||
13-37637117-A-T | not specified | Uncertain significance (Oct 13, 2021) | ||
13-37637153-C-T | not specified | Uncertain significance (May 30, 2024) | ||
13-37637169-C-G | not specified | Uncertain significance (Apr 15, 2024) | ||
13-37637169-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
13-37637201-G-T | not specified | Uncertain significance (Jun 07, 2023) | ||
13-37637211-C-G | not specified | Uncertain significance (Jul 13, 2022) | ||
13-37637219-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
13-37637264-T-C | not specified | Uncertain significance (Nov 18, 2022) | ||
13-37637265-C-G | not specified | Uncertain significance (Mar 16, 2024) | ||
13-37637342-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
13-37637415-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
13-37637534-G-A | not specified | Uncertain significance (Nov 18, 2023) | ||
13-37637558-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
13-37639074-T-C | not specified | Uncertain significance (Jun 21, 2022) | ||
13-37639099-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
13-37639290-C-T | not specified | Uncertain significance (Apr 28, 2022) | ||
13-37651293-C-A | not specified | Uncertain significance (May 23, 2023) | ||
13-37651446-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
13-37663428-T-G | not specified | Uncertain significance (Jun 17, 2024) | ||
13-37663461-G-A | not specified | Uncertain significance (Mar 11, 2024) | ||
13-37674318-G-T | not specified | Uncertain significance (Jun 10, 2024) | ||
13-37692047-C-T | not specified | Uncertain significance (Feb 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRPC4 | protein_coding | protein_coding | ENST00000379681 | 10 | 233790 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.482 | 0.518 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.61 | 353 | 521 | 0.678 | 0.0000273 | 6439 |
Missense in Polyphen | 92 | 212.69 | 0.43255 | 2715 | ||
Synonymous | -0.829 | 216 | 201 | 1.07 | 0.0000112 | 1890 |
Loss of Function | 4.87 | 10 | 45.5 | 0.220 | 0.00000261 | 527 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000621 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000328 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Form a receptor-activated non-selective calcium permeant cation channel. Acts as a cell-cell contact-dependent endothelial calcium entry channel. Probably operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Mediates cation entry, with an enhanced permeability to barium over calcium. May also be activated by intracellular calcium store depletion. {ECO:0000269|PubMed:16144838, ECO:0000269|PubMed:19996314}.;
- Pathway
- Axon guidance - Homo sapiens (human);ion channels and their functional role in vascular endothelium;Stimuli-sensing channels;Ion channel transport;Transport of small molecules;TRP channels
(Consensus)
Intolerance Scores
- loftool
- 0.541
- rvis_EVS
- -1.18
- rvis_percentile_EVS
- 5.97
Haploinsufficiency Scores
- pHI
- 0.478
- hipred
- Y
- hipred_score
- 0.725
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.866
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trpc4
- Phenotype
- muscle phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- calcium ion transport;manganese ion transport;gamma-aminobutyric acid secretion;oligodendrocyte differentiation;regulation of cytosolic calcium ion concentration;calcium ion import;calcium ion transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;caveola;cell-cell junction;cell surface;basolateral plasma membrane;cortical cytoskeleton;cation channel complex;calcium channel complex
- Molecular function
- calcium channel activity;protein binding;beta-catenin binding;store-operated calcium channel activity;cadherin binding;inositol 1,4,5 trisphosphate binding